Biotech Attovia Therapeutics Climbs 24% After $289 Million IPO
Attovia Therapeutics Inc. shares jumped 24% in its trading debut, after the early-stage drug developer focused on immune system diseases raised $289 million in a US initial public offering.
2 sources
·2d ago